HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) All Versions of this Article: 2433060838v1 243/3/670    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Pediconi, F. Articles by Passariello, R. Search for Related Content PubMed PubMed Citation Articles by Pediconi, F. Articles by Passariello, R.

Contrast-enhanced MR Mammography for Evaluation of the Contralateral Breast in Patients with Diagnosed Unilateral Breast Cancer or High-Risk Lesions¹

¹ From the Departments of Radiological Sciences (F.P., C.C., A.R., S.P., F.A., E.M., R.P.) and Surgery (A.M.P.), University of Rome "La Sapienza," Viale Regina Elena, 324, 00161 Rome, Italy; and Department of Worldwide Medical Affairs, Bracco Imaging, Milan, Italy (M.A.K.). Received May 13, 2006; revision requested July 13; revision received July 24; accepted August 23; final version accepted October 5. Address correspondence to F.P. (e-mail: federica.pediconi{at}uniroma1.it).

Purpose: To prospectively evaluate accuracy of gadobenate dimeglumine–enhanced magnetic resonance (MR) mammography for depiction of synchronous contralateral breast cancer in patients with newly diagnosed unilateral breast cancer or high-risk lesions, with histologic analysis or follow-up as reference.

Materials and Methods: The study had ethics committee approval; all patients provided written informed consent. One hundred eighteen consecutive women (mean age, 52 years) with unilateral breast cancer or high-risk lesions and negative findings in the contralateral breast at physical examination, ultrasonography, and conventional mammography underwent gadobenate dimeglumine–enhanced 1.5-T MR mammography. Transverse three-dimensional T1-weighted gradient-echo images were acquired before and at 0, 2, 4, 6, and 8 minutes after gadobenate dimeglumine administration (0.1 mmol per kilogram body weight). Breast Imaging Reporting and Data System (BI-RADS) was used to categorize breast density and the level of suspicion for malignant contralateral breast lesions. Results were compared with histologic findings. Sensitivity, specificity, accuracy, and positive and negative predictive values for contrast-enhanced MR mammography were evaluated.

Results: Contrast-enhanced MR mammography revealed contralateral lesions in 28 (24%) of 118 patients. Twenty-four lesions were detected in patients with dense breasts (BI-RADS breast density category III or IV). Lesions in eight (29%) of 28 patients were BI-RADS category 4; patients underwent biopsy. Lesions in 20 (71%) patients were BI-RADS category 5; patients underwent surgery. At histologic analysis, 22 lesions were confirmed as malignant; six lesions were fibroadenomas. No false-negative lesions were detected; none of the fibroadenomas were BI-RADS category 5. The sensitivity, specificity, accuracy, and positive and negative predictive values of contrast-enhanced MR mammography for depiction of malignant or high-risk contralateral lesions were 100%, 94%, 95%, 79%, and 100%, respectively. Follow-up findings (12–24 months) confirmed absence of contralateral lesions in 90 of 118 patients with negative contrast-enhanced MR mammographic findings in the contralateral breast.

Conclusion: Contrast-enhanced MR mammography is accurate for detection of synchronous contralateral cancer or high-risk lesions in patients with newly diagnosed breast cancer or high-risk lesions.

© RSNA, 2007

This article has been cited by other articles:

				N. Taira, S. Ohsumi, D. Takabatake, F. Hara, S. Takashima, K. Aogi, S. Takashima, T. Inoue, S. Sugata, and R. Nishimura Contrast-enhanced CT Evaluation of Clinically and Mammographically Occult Multiple Breast Tumors in Women with Unilateral Early Breast Cancer Jpn. J. Clin. Oncol., June 1, 2008; 38(6): 419 - 425. [Abstract] [Full Text] [PDF]

				N. Hoogerbrugge, Y. J. L. Kamm, P. Bult, K. M. Landsbergen, E. M. H. F. Bongers, H. G. Brunner, H. J. Bonenkamp, J. A. de Hullu, M. J. L. Ligtenberg, and C. Boetes The impact of a false-positive MRI on the choice for mastectomy in BRCA mutation carriers is limited Ann. Onc., April 1, 2008; 19(4): 655 - 659. [Abstract] [Full Text] [PDF]

				S. Orel Who Should Have Breast Magnetic Resonance Imaging Evaluation? J. Clin. Oncol., February 10, 2008; 26(5): 703 - 711. [Abstract] [Full Text] [PDF]

				M. J. Kim, E.-K. Kim, J. Y. Kwak, B.-W. Park, S.-I. Kim, J. Sohn, and K. K. Oh Role of Sonography in the Detection of Contralateral Metachronous Breast Cancer in an Asian Population Am. J. Roentgenol., February 1, 2008; 190(2): 476 - 480. [Abstract] [Full Text] [PDF]